On Oct 16, FDA approved pembrolizumab with platinum-containing chemotherapy as neoadjuvant treatment and with continuation of single-agent pembrolizumab as adjuvant treatment for resectable (tumors ≥4 cm or node positive) non-small cell lung cancer
Any dots to be joined here?
- Forums
- ASX - By Stock
- Media
On Oct 16, FDA approved pembrolizumab with platinum-containing...
-
- There are more pages in this discussion • 217 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
43.5¢ |
Change
-0.010(2.25%) |
Mkt cap ! $517.1M |
Open | High | Low | Value | Volume |
44.0¢ | 45.0¢ | 43.0¢ | $618.8K | 1.404M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 21064 | 43.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
44.0¢ | 1500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5695 | 0.440 |
2 | 134806 | 0.435 |
8 | 48602 | 0.430 |
6 | 64787 | 0.425 |
8 | 87794 | 0.420 |
Price($) | Vol. | No. |
---|---|---|
0.405 | 56 | 1 |
0.430 | 1000 | 1 |
0.435 | 25000 | 2 |
0.440 | 1280 | 1 |
0.445 | 50000 | 2 |
Last trade - 16.10pm 16/05/2024 (20 minute delay) ? |
|
|||||
Last
44.0¢ |
  |
Change
-0.010 ( 2.68 %) |
|||
Open | High | Low | Volume | ||
44.0¢ | 45.0¢ | 43.0¢ | 344370 | ||
Last updated 15.59pm 16/05/2024 ? |
Featured News
IMM (ASX) Chart |